1. insights
  2. strategy catalyst
  3. healthcare services
  4. penn gene therapy program closes as director leaves to form for profits
Strategist | strategy-catalyst

Penn Gene Therapy Program closes, as director leaves to form for-profits

The Strategist lead image for web
Related Topics:
Healthcare Services
Relevant Roles:
Chief Strategy Officers

Last month, gene therapy pioneer Jim Wilson announced plans to leave his position as director of the University of Pennsylvania's GTP to launch two new companies: Gemma Biotherapeutics and Franklin Biolabs. Wilson had founded the GTP as the first and largest gene therapy program after coming to Penn in 1993.